Safer Medication Administration Through Design and Ergonomics

Chapter

Abstract

Safe medication management is a major focus of all of the stakeholders in the surgical ambulatory and hospital service arena. There are key elements which must be in place according to contemporary standards and regulatory and/or accrediting bodies. Adverse drug events cause substantial morbidity and mortality, yet they remain underappreciated and misunderstood. The terminology to describe errors and patient harm associated with medications causes much confusion. Medication errors are the number one cause of preventable adverse events, including death. System checks should be designed into the medication administration process to prevent or reduce chances of inadvertent drug/vial swap. There needs to be, among other expectations, prudent formulary management, closely managed controlled drug systems, ongoing focused education of staff, due diligence in purchasing in general and compounding pharmacy selection in specific, and unwavering support for safe injection practices. Also emphasized are the role and rationale for meaningful documentation of adverse drug events and the role of the pharmacist, along with an outline of the types of events that should be reported to regulatory agencies, pivotal in the goal of safe medication management. This chapter will be divided into two parts: Part I deals with managing adverse medication events in the operating room based upon a real event and Part II addresses ambulatory medication safety and regulatory oversight.

Keywords

Medication safety Pharmacy Formulary Controlled drugs Compounding Recalls Emergent response Medication education Pharmacist Safety culture Reporting systems Adverse medication events 

References

  1. 1.
    Ross SD. Drug-related adverse events: a readers’ guide to assessing literature reviews and meta-analyses. Arch Intern Med. 2001;161:1041–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Shojania KG, Duncan BW, McDonald KM, Wachter RM. Safe but sound: patient safety meets evidence-based medicine [Editorial]. JAMA. 2002;288:508–13.CrossRefPubMedGoogle Scholar
  3. 3.
    Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Washington, DC: National Academy Press; 1999.Google Scholar
  4. 4.
    Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274:29–34.CrossRefPubMedGoogle Scholar
  5. 5.
    Gandhi TK, Weingart SN, Borus J, Seger AC, Peterson J, Burdick E, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556–64.CrossRefPubMedGoogle Scholar
  6. 6.
    Fattinger K, Roos M, Vergeres P, Holenstein C, Kind B, Masche U, et al. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. Br J Clin Pharmacol. 2000;49:158–67.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266:2847–51.CrossRefPubMedGoogle Scholar
  8. 8.
    Tegeder I, Levy M, Muth-Selbach U, Oelkers R, Neumann F, Dormann H, et al. Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol. 1999;47:557–64.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Nebeker JR, Hurdle JF, Hoffman JM, Roth B, Weir CR, Samore MH. Developing a taxonomy for research in adverse drug events: potholes and sign-posts. J Am Med Inform Assoc. 2002;9(6 Suppl):S80–5.CrossRefPubMedCentralGoogle Scholar
  10. 10.
    Schlienger RG, Luscher TF, Schoenenberger RA, Haefeli WE. Academic detailing improves identification and reporting of adverse drug events. Pharm World Sci. 1999;21:110–5.CrossRefPubMedGoogle Scholar
  11. 11.
    Johnstone DM, Kirking DM, Vinson BE. Comparison of adverse drug reactions detected by pharmacy and medical records departments. Am J Health Syst Pharm. 1995;52:297–301.PubMedGoogle Scholar
  12. 12.
    Sivaram CA, Johnson S, Tirmizi SN, Robertson V, Garcia D, Sorrells E. Morning report: a forum for reporting adverse drug reactions. Jt Comm J Qual Improv. 1996;22:259–63.PubMedGoogle Scholar
  13. 13.
    Thatcher C. ADR: reporting problems. Can Pharm J. 2002;134:11.Google Scholar
  14. 14.
    Hofer TP, Kerr EA, Hayward RA. What is an error? Eff Clin Pract. 2000;3:261–9.PubMedGoogle Scholar
  15. 15.
    Nick G, editor. Manual of complications during anesthesia. Philadelphia, PA: Lippincott; 1991.Google Scholar
  16. 16.
    Cooper JB. Toward prevention of anesthetic mishaps. Int Anesthesiol Clin. 1984;22:167–83.CrossRefPubMedGoogle Scholar
  17. 17.
    Lunn JN, Devlin HB. Lessons from the confidential enquiry into perioperative deaths in three NHS regions. Lancet. 1987;12:1384–6.CrossRefGoogle Scholar
  18. 18.
    Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Institute of Medicine. Committee on Quality of Health Care in America. Washington, DC: National Academy Press; 1999.Google Scholar
  19. 19.
    Bates DW, Cullen D, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1955;274:29–34.CrossRefGoogle Scholar
  20. 20.
    Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324:377–84.CrossRefPubMedGoogle Scholar
  21. 21.
    National Association of Insurance Commissioners. Medical malpractice closed claims, 1975–1978. Brookfield, WI: National Association of Insurance Commissioners; 1980.Google Scholar
  22. 22.
    Nanji KC, Patel A, Shaikh S, Seger DL, Bates DW. Evaluation of perioperative medication errors and adverse drug events. Anesthesiology. 2016;124(1):25–34. doi: 10.1097/ALN.0000000000000904.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Barker KN, Flynn EA, Pepper GA. Observation method of detecting medication errors. Am J Health Syst Pharm. 2002;59:2314–6.PubMedGoogle Scholar
  24. 24.
    Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM, Burdick E, Hickey M, Kleefield S, Shea B, Vander Vliet M, Seger DL. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 1998;280:1311–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Poon EG, Cina JL, Churchill W, Patel N, Featherstone E, Rothschild JM, Keohane CA, Whittemore AD, Bates DW, Gandhi TK. Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy. Ann Intern Med. 2006;145:426–34.CrossRefPubMedGoogle Scholar
  26. 26.
    Leape LL, Bates DW, Cullen DJ, Cooper J, Demonaco HJ, Gallivan T, et al. Systems analysis of adverse drug events. JAMA. 1995;274:35–43.CrossRefPubMedGoogle Scholar
  27. 27.
    Reason JT, Carthey J, de Leval MR. Diagnosing “vulnerable system syndrome”: an essential prerequisite to effective risk management. Qual Health Care. 2001;10:ii21–5.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Currie M, Mackay P, Morgan C, et al. The “wrong drug” problem in anesthesia: an analysis of 2000 incident reports. Anaesth Intensive Care. 1993;21:596–601.PubMedGoogle Scholar
  29. 29.
    Russell WJ. Getting in the red: a strategic step for safety. Qual Saf Health Care. 2002;11:107.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Cooper JB, Newbower RS, Kitz RJ. An analysis of major errors and equipment failures in anesthesia management: considerations for prevention and detection. Anesthesiology. 1984;60:34–42.CrossRefPubMedGoogle Scholar
  31. 31.
    Tissot E, Cornettte C, Demoly P, et al. Medication errors at the administration stage in an intensive care unit. Intensive Care Med. 1999;25:353–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Gaba DM, Maxwell M, DeAnda A. Anesthetic mishaps: breaking the chain of accident evolution. Anesthesiology. 1987;66:670–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Smith JW, Seidl LG, Cluff LE. Studies on epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. Ann Intern Med. 1966;65:629–40.CrossRefPubMedGoogle Scholar
  34. 34.
    Reason J. A preliminary classification of mistakes. In: Rasumussen J, Duncan K, Lelpat J, editors. New technology and human error. Chiseter: Wiley; 1987. p. 15–22.Google Scholar
  35. 35.
    Rasmussen J. Information processing and human-machine interaction: an approach to cognitive engineering. New York, NY: Elsevier; 1986. p. 149–51.Google Scholar
  36. 36.
    American Society for Testing and Materials. Standard specification for user applied drug labels in anesthesiology. Conshohocken, PA: American Society for Testing and Materials; 1995. D477494.Google Scholar
  37. 37.
    Sudo RT, Carmo PL, Trachez MM, Zapata-Sudo G. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle. Basic Clin Pharmacol Toxicol. 2008;102(3):308–16. doi: 10.1111/j.1742-7843.2007.00156.x.CrossRefPubMedGoogle Scholar
  38. 38.
    Mackeen AD, Packard RE, Ota E, Berghella V, Baxter JK. Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery. Cochrane Database Syst Rev. 2014;12, CD009516. doi: 10.1002/14651858.CD009516.pub2.Google Scholar
  39. 39.
    Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett. 2012;10(122):73–8.Google Scholar
  40. 40.
    Barach P. The role of anesthesiologists in preparing for nuclear, chemical and biological hazards and civilian preparedness. Anesthesia Refresher Course, American Society of Anesthesia; 2003. p. 273.Google Scholar
  41. 41.
    Rivkind A, Eid A, Durst A, Weingart E, Barach P, Richter E. Complications from supervised mask use in post-operative surgical patients during the Gulf War. Prehosp Disaster Med. 1999;14(2):107–8.Google Scholar
  42. 42.
    Barach P, Pretto E. Chemical and radiation injuries. In: Lobato EB, Gravenstein N, Kirby RR, editors. Complications in anesthesiology. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 962–73.Google Scholar
  43. 43.
    Barach P, Pretto E. Current concepts in treatment of agents of mass destruction. In: AJ Schwartz, editor. ASA Refresher Course Publication, vol. 33. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 305.Google Scholar
  44. 44.
    Small SD, Barach P. Patient safety and health policy: a history and review. Hematol Oncol Clin North Am. 2002;16(6):1463–82.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Safe Medication Management & Pharmacy Consulting ServicesNewingtonUSA
  2. 2.Children’s Cardiomyopathy Foundation and Kyle John Rymiszewski Research ScholarChildren’s Hospital of Michigan, Wayne State University School of MedicineDetroitUSA

Personalised recommendations